NCT05425888 is a clinical trial of Hemophilia group in Haemophilia, sponsored by Investigación en Hemofilia y Fisioterapia.

Who is sponsoring NCT05425888?

NCT05425888 is sponsored by Investigación en Hemofilia y Fisioterapia.

What drugs are being tested in NCT05425888?

Interventions in NCT05425888: Hemophilia group.

What condition does NCT05425888 study?

NCT05425888 studies Haemophilia.

Is NCT05425888 still recruiting?

NCT05425888 is currently completed. Last updated 9 February 2024.

Last reviewed 2024-02-09 · How we verify

NCT05425888

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Functional and Proprioceptive Status in Patients With Hemophilic Ankle Arthropathy

Completed Last updated 9 February 2024

What this trial tests

trial testing Hemophilia group in Haemophilia in 32 participants. Completed in 23 December 2022.

Timeline

22 June 2022

Primary endpoint
18 November 2022

23 December 2022

Quick facts

Lead sponsor	Investigación en Hemofilia y Fisioterapia
Status	Completed
Study type	OBSERVATIONAL
Enrollment	32
Start date	22 June 2022
Primary completion	18 November 2022
Estimated completion	23 December 2022
Sites	1 location across Spain

Drugs / interventions tested

Hemophilia group

Conditions studied

Haemophilia — all drugs for Haemophilia →

Sponsor

Investigación en Hemofilia y Fisioterapia

Who can join

Adults 18 to 45, male only, with Haemophilia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Introduction: Hemophilic ankle arthropathy is manifested by functional degenerative alterations (muscle strength deficit, mobility and proprioception), intra-articular and chronic pain. Design: Case-control study. Objective: To observe the differences between patients with hemophilic ankle arthropathy and their healthy peers, regarding dorsiflexion, dorsiflexion strength, biomechanical analysis of gait and balance, and functionality. Patients: 10 patients with hemophilic ankle arthropathy and 12 healthy subjects without ankle joint damage. Measurement instruments and study variables: dorsiflexion (range of motion), dorsiflexion strength (dynamometry), biomechanical analysis of gait and balance (RS SCAN® model platform), and functionality (2 Minute Walk Test). Expected results: Analyze the main differences and their relationship based on the clinical and independent variables of patients with hemophilia, compared to their healthy peers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Stability, Balance, and Physical Variables in Patients with Bilateral Hemophilic Arthropathy of the Ankle versus Their Healthy Peers: A Case-Control Study.
Truque-Díaz C, Meroño-Gallut J, Molina-García C, Cuesta-Barriuso R, et al · · 2024 · cited 2× · PMID 39202791 · DOI 10.3390/life14081051

Verify or expand the search:

Other Investigación en Hemofilia y Fisioterapia trials

Trials by the same sponsor.

NCT07516730 — Central Pain Mechanisms and Clinical and Psychological Factors Associated With Pain Interference in Daily Life in Adults · not yet recruiting
NCT07483541 — Identification of Modifiable Sleep-related Factors in Patients With Systemic Lupus Erythematosus. · not yet recruiting
NCT07420387 — Effectiveness of an Educational Program for Pain Management in Patients With Hemophilic Arthropathy · NA · not yet recruiting
NCT07420348 — Incidence of Ultrasonographically Detected Articular Damage in Initially Healthy Joints of Patients With Hemophilia A Re · not yet recruiting
NCT07123220 — Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05425888 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Investigación en Hemofilia y Fisioterapia
Last refreshed: 9 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05425888.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing